Race, racism, and cardiovascular health: applying a social determinants of health framework to racial/ethnic disparities in cardiovascular disease

…, Z Amin, I Acquah, J Valero-Elizondo… - … Quality and Outcomes, 2022 - Am Heart Assoc
Health care in the United States has seen many great innovations and successes in the past
decades. However, to this day, the color of a person’s skin determines—to a considerable …

National trends in statin use and expenditures in the US adult population from 2002 to 2013: insights from the medical expenditure panel survey

JA Salami, H Warraich, J Valero-Elizondo… - JAMA …, 2017 - jamanetwork.com
Importance Statins remain a mainstay in the prevention and treatment of atherosclerotic
cardiovascular disease (ASCVD). Objective To detail the trends in use and total and out-of-…

Trends in differences in health status and health care access and affordability by race and ethnicity in the United States, 1999-2018

S Mahajan, C Caraballo, Y Lu, J Valero-Elizondo… - Jama, 2021 - jamanetwork.com
Importance The elimination of racial and ethnic differences in health status and health care
access is a US goal, but it is unclear whether the country has made progress over the last 2 …

Social determinants of health and cardiovascular disease: current state and future directions towards healthcare equity

MH Jilani, Z Javed, T Yahya, J Valero-Elizondo… - Current atherosclerosis …, 2021 - Springer
Purpose of Review We sought to examine the role of social and environmental conditions
that determine an individual’s behaviors and risk of disease—collectively known as social …

Cost-related medication nonadherence in adults with atherosclerotic cardiovascular disease in the United States, 2013 to 2017

R Khera, J Valero-Elizondo, SR Das, SS Virani… - Circulation, 2019 - Am Heart Assoc
Background: Medication nonadherence is associated with worse outcomes in patients with
atherosclerotic cardiovascular disease (ASCVD), a group who requires long-term therapy for …

Social determinants of health and obesity: Findings from a national study of US adults

Z Javed, J ValeroElizondo, MH Maqsood, S Mahajan… - …, 2022 - Wiley Online Library
Objective This study examined the association between social determinants of health (SDOH)
burden and overweight/obesity in a nationally representative sample of adults in the …

Financial toxicity in atherosclerotic cardiovascular disease in the United States: current state and future directions

R Khera, J Valero-Elizondo, K Nasir - Journal of the American …, 2020 - Am Heart Assoc
… Data from studies by Khera et al 15 and ValeroElizondo et al. ASCVD indicates atherosclerotic
… † Dr Khera and Dr ValeroElizondo contributed equally to this work as co‐first authors. …

Gender differences in patient‐reported outcomes among adults with atherosclerotic cardiovascular disease

V Okunrintemi, J ValeroElizondo… - Journal of the …, 2018 - Am Heart Assoc
Background Atherosclerotic cardiovascular disease ( ASCVD ) accounts for approximately
one third of deaths in women. Although there is an established relationship between positive …

Association of subjective and objective sleep duration as well as sleep quality with non-invasive markers of sub-clinical cardiovascular disease (CVD): a systematic …

M Aziz, SS Ali, S Das, A Younus, R Malik… - … of atherosclerosis and …, 2017 - jstage.jst.go.jp
Aim: Abnormal daily sleep duration and quality have been linked to hypertension, diabetes,
stroke, and overall cardiovascular disease (CVD) morbidity& mortality. However, the …

Patient–provider communication and health outcomes among individuals with atherosclerotic cardiovascular disease in the United States: Medical Expenditure Panel …

…, P Di Capua, JA Salami, J Valero-Elizondo… - … Quality and Outcomes, 2017 - Am Heart Assoc
Background— Consumer-reported patient–provider communication (PPC) assessed by
Consumer Assessment of Health Plans Survey in ambulatory settings is incorporated as a …